Related Experiment Videos
Clinical cross-over trials in phase I.
1Department of Statistical Science, University College London, UK. stephens@public-health.ucl.ac.uk
Statistical Methods in Medical Research
|January 15, 2000
Summary
Cross-over trials are crucial for pharmacokinetic and pharmacodynamic studies, especially in Phase I clinical trials. This review covers essential design, analysis, and planning considerations for these trials.
Area of Science:
- Pharmacology
- Clinical Trial Design
Background:
- Pharmacokinetic (PK) and pharmacodynamic (PD) studies are essential for drug development.
- Cross-over trial designs are frequently employed in early-phase clinical studies.
Purpose of the Study:
- To review the application of cross-over trials in PK/PD studies.
- To discuss design, analysis, and planning considerations for these trials.
Main Methods:
- Literature review of cross-over trial applications in PK/PD.
- Discussion of theoretical and practical aspects of trial design and analysis.
Main Results:
- Cross-over trials offer efficient evaluation of PK/PD relationships.
- Key considerations include study design, statistical analysis, and practical implementation.
Conclusions:
- Cross-over trials are valuable tools in PK/PD research, particularly in Phase I.
- Effective planning and analysis are critical for successful implementation.